维普中文期刊产品整合服务
168篇 您的检索式:作者名="Tollefson GD"
    题名 作者 年代 出处 被引量
1Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia显示文摘Dellva MA Tran P Tollefson GD 1997Psychiatr Serv1997,48,:1
2Efficacy of olanzapine: an overview of pitotal clinical trials显示文摘Beasley CM Tollefson GD Tran PV 1997J Clin Psychiatry1997,58,10:1
3Double-blind comparison of olazapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine显示文摘Tollefson GD Birkett MA Kiesler GM 2001Biological psychiatry2001,49,1:1
4A novel augmentation strategy for treating resistant major depression显示文摘Shehon RC Tollefson GD Tohen M 2001Am J Psychiatry2001,158,:1
5The efficacy of Olanzap- ine:the summary of? global,multicentral clinical? trials显示文摘Beasley CM Tollefson GD Tran PV 1997J Clin Psychiatry1997,58,110:1
6A novel augmentation strategy for treating resistant major depression显示文摘Shelton RC Tollefson GD Tohen M et al 2001Am J Psychiatry2001,158,1:1
7Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine显示文摘Tollefson GD Birkett MA Kiesler GM 2001Biol Psychiatry2001,49,:1
8A novel augmentation strategy for treating resistant major depression显示文摘Sheiton RC Tollefson GD Tohen M 2001Am J Psychiatry2001,158,1:1
9Th e acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations显示文摘Crawford AM Beasley CM Jr Tollefson GD 1997Schizophr Res1997,26,1:1
10A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder显示文摘Tollefson GD Rampey AHJr Potvin JH 1994Arch Gen Psychiatry1994,51,7:1
11A novel augmentation strategy for treating resistant major depression显示文摘Shelton RC Tollefson GD TohenM 0,,01:1
12Double-blind comparison of olazapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine显示文摘 Birkett MA Kiesler GM 2001Biological Psychiatry2001,49,1:1
13A novel augmentation strategy for treating resisting major depression显示文摘Shelton RC Tollefson GD Tohen M 0,,01:1
14A double-blind,controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia显示文摘Tollefson GD Sanger TM Beasley CM 0,,11:1
15A novel augmen- tation strategy for treating resistant major depression显示文摘Shelton RC Tollefson GD TohenM 2001Am J Psychiatry2001,158,1:1
16Safety of Quetiapine显示文摘Beasley CM Tollefson GD Tran PV 1997Clin Psychiatry1997,58,10:1
17A novel augmentation strategy for treating resistant major depression显示文摘Shelton RC Tollefson GD Tohen M 2001Am J Psychiatry2001,158,1:1
18Analysis of the hamilton depression rating scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression显示文摘 Holman SL 1993Int Clin Psychopharmacol1993,8,4:1
19Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia显示文摘Tran PV Dellva MA Tollefson GD 1997J Clin Psychiatry1997,58,3:1
20A novel augmentation strategy for treating resistant major depression显示文摘 Tollefson GD Tohen M 2001Am J psychiatry2001,158,:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费